Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.36 USD | -5.56% | -12.82% | -28.04% |
01:00pm | Adicet Bio Receives FDA Fast Track Designation for ADI-001 in Lupus Nephritis | CI |
05-14 | Adicet Bio, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
End-of-day quotes
Sector Other Biotechnology & Medical Research
Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
---|---|---|---|---|---|---|
112M | - | - | - | - | - | |
55.7B | - | |||||
39.57B | ||||||
39.91B | ||||||
28.16B | ||||||
26.3B |
- Stock Market
- Equities
- ACET Stock
- Charts Adicet Bio, Inc.
- Sector Chart